Form 4 holding
10%+ Owner
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 4,523,924
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- By Vida Ventures, LLC
Vida Ventures, LLC
Insider Reports History
- Location
- Boston, MA
- Owner filing signature
- Vida Ventures, LLC By: /s/ Fred E. Cohen, its Senior Managing Director
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 identity field
SEC source record
1 source field
Source evidence
1 source field
Reported holdings for Vida Ventures, LLC
Form 4 holding
10%+ Owner
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 252,553
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- By Vida Ventures III, L.P.
Form 4 holding
10%+ Owner
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 583
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- By Vida Ventures III-A, L.P.
Form 4 holding
10%+ Owner
Kyverna Therapeutics, Inc.
- Security class
- Series A-1 Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- By Vida Ventures, LLC
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Kyverna Therapeutics, Inc.
- Security class
- Series A-2 Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- By Vida Ventures, LLC
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Kyverna Therapeutics, Inc.
- Security class
- Series B Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- By Vida Ventures, LLC
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Vida Ventures, LLC
4
KYTX
Kyverna Therapeutics, Inc.
- Report period
- 12 Feb 2024
- Transactions
- 6
- Transaction value
- +$5,568,992
- Accepted by SEC
- 14 Feb 2024, 19:04
- Role
- 10%+ Owner
- Next action
- Open filing details
3
KYTX
Kyverna Therapeutics, Inc.
- Report period
- 07 Feb 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 07 Feb 2024, 21:56
- Role
- 10%+ Owner
- Next action
- Open filing details